New heart valve device tested in 20 patients with severe leaky valve

NCT ID NCT07450911

First seen Mar 11, 2026 · Last updated May 14, 2026 · Updated 7 times

Summary

This early study tests a new device called the ReValve System to replace the mitral valve in people with severe mitral regurgitation (a leaky heart valve). The goal is to see if the device can be safely delivered and reduce the leak. The study involves 20 people who need mitral valve surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Healthycore

    RECRUITING

    Tbilisi, Georgia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tbilisi Heart and Vascular Center

    RECRUITING

    Tbilisi, Georgia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tiblisi Heart Center

    RECRUITING

    Tbilisi, Georgia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.